{"id":"W4389241939","doi":"10.1158/1535-7163.targ-23-pr003","title":"Abstract PR003: Repotrectinib in patients with <i>ROS1</i> fusion-positive (<i>ROS1</i>+) non-small cell lung cancer (NSCLC): Update from the pivotal phase 1/2 TRIDENT-1 trial","year":2023,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; ROS1; Cohort; Clinical endpoint; Lung cancer; Oncology; Cancer; Clinical trial; Adenocarcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001594088,0.0004405843,0.0005010698,0.0001344138,0.0002321677,0.0000937677,0.0002274863,0.0001527603,0.0001625678],"category_scores_gemma":[0.00001202881,0.0003007442,0.0001999826,0.0008474939,0.00009422133,0.0001101179,0.00006615929,0.0004548245,0.00002320435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005099667,"about_ca_system_score_gemma":0.0008502539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002622137,"about_ca_topic_score_gemma":0.0008254388,"domain_scores_codex":[0.9974639,0.00009192005,0.0005394435,0.000676361,0.000635855,0.0005924685],"domain_scores_gemma":[0.9985315,0.0001382794,0.0003135512,0.0006135317,0.0002383712,0.0001647751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1619689,0.01224403,0.5341155,0.0004232437,0.01028369,0.002371393,0.02045759,0.003695308,0.07527974,0.00004173267,0.009736612,0.1693823],"study_design_scores_gemma":[0.4743255,0.003323857,0.4108251,0.001957985,0.006939894,0.000006183991,0.000922999,0.001762167,0.08620693,0.00008414808,0.01193443,0.001710789],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892238,0.002767056,0.000252209,0.001823698,0.001005506,0.003386633,0.0009020937,0.0001047769,0.0005341709],"genre_scores_gemma":[0.9925013,0.0007997597,0.0001227994,0.004077991,0.0003027029,0.0009484241,0.0007245929,0.0001263717,0.0003960366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3123567,"threshold_uncertainty_score":0.9999444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01375812211271293,"score_gpt":0.317288329426474,"score_spread":0.3035302073137611,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}